Endpoints News Jan 6, 2026 Alumis' TYK2 drug succeeds in key psoriasis studies, will seek FDA approval
Thermo Fisher Jan 6, 2026 Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - PharmiWeb.com
Cell Jan 6, 2026 A glycolytic shunt via the pentose phosphate pathway is a metabolic checkpoint for nervous system sensory homeostasis and axonal regeneration
FierceBiotech Jan 6, 2026 Arrowhead takes aim at obesity market with early data on dual gene silencing assets
FierceBiotech Jan 6, 2026 In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
FierceBiotech Jan 6, 2026 Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
FierceBiotech Jan 6, 2026 Bright Minds shines with phase 2 win for anti-seizure serotonin receptor activator
FierceBiotech Jan 6, 2026 Boehringer continues kidney disease dealmaking run with $120M Variant Bio pact
Thermo Fisher Jan 6, 2026 Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treat - PharmiWeb.com